CDT Equity Inc.
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
CDT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6266422012 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 4851 TAMIAMI TRAIL NORTH, 34103 NAPLES
- Website:
- https://www.cdtequity.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CDT Equity Inc., formerly Conduit Pharmaceuticals, is a clinical-stage, data-driven biopharmaceutical development company. It focuses on identifying, enhancing, and advancing high-potential therapeutic assets to address unmet medical needs. The company's platform leverages artificial intelligence, advanced solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. Through its co-crystallization technologies, CDT Equity aims to improve drug properties and extend patent life. The company creates value through licensing, strategic partnerships, and mergers and acquisitions, positioning itself as a platform for transformative innovation in the biopharmaceutical sector.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CDT Equity Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CDT Equity Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CDT Equity Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
